By oral administration of a compound represented by the following Formula (I):the blood level of Compound (IV):which has an excellent inhibitory action against blood coagulation factor VIIa and the anticoagulant action, reaches a level sufficient for expression of its pharmacological actions. Therefore, the compound of the present invention is useful as a therapeutic and/or prophylactic agent for diseases caused by thrombus formation.經口投藥下列式(I)所示之化合物：具有極佳之對抗凝血因子VIIa的抑制作用及抗凝血作用之化合物(IV)的血中濃度：可達到足以表現出其藥理作用的水準。因此，本發明之化合物可用作為因血栓形成所造成之疾病的治療及/或預防劑。
